JDVNX
Price
$23.10
Change
-$0.34 (-1.45%)
Updated
Mar 3 closing price
Net Assets
16.29B
VIVAX
Price
$68.85
Change
-$0.64 (-0.92%)
Updated
Mar 3 closing price
Net Assets
192.55B
Ad is loading...

JDVNX vs VIVAX

Header iconJDVNX vs VIVAX Comparison
Open Charts JDVNX vs VIVAXBanner chart's image
JHancock Disciplined Value NAV
Price$23.10
Change-$0.34 (-1.45%)
VolumeN/A
Net Assets16.29B
Vanguard Value Index I
Price$68.85
Change-$0.64 (-0.92%)
VolumeN/A
Net Assets192.55B
JDVNX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDVNX vs. VIVAX commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVNX is a Buy and VIVAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 193B vs. JDVNX (16.3B). VIVAX pays higher dividends than JDVNX: VIVAX (2.25) vs JDVNX (1.02). JDVNX was incepted earlier than VIVAX: JDVNX (16 years) vs VIVAX (32 years). JDVNX is a more actively managed with annual turnover of: 43.00 vs. VIVAX (10.00). JDVNX has a lower initial minimum investment than VIVAX: JDVNX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 14.32 vs. JDVNX (1.07). VIVAX return over 5 years is better than : 69.39 vs. JDVNX (38.64).
JDVNXVIVAXJDVNX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years32 years-
Gain YTD4.0395.19278%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets16.3B193B8%
Annual Yield % from dividends1.022.2546%
Returns for 1 year1.0714.327%
Returns for 3 years6.5825.9325%
Returns for 5 years38.6469.3956%
Returns for 10 years38.65109.2435%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOOP1.330.05
+3.50%
Loop Industries
ATMU39.801.20
+3.11%
Atmus Filtration Technologies
MBRX1.290.02
+1.57%
Moleculin Biotech
CCRN17.16-0.11
-0.64%
Cross Country Healthcare
EXAS47.41-0.41
-0.86%
Exact Sciences Corp